Wells Fargo’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
VCM
Wells Fargo's RXST Position: Q1 2026 in Review
Wells Fargo reduced its RxSight (RXST) stake by 69% in Q1 2026, selling an estimated $625K and leaving 33,237 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #4692.
Wells Fargo first reported a position in RXST in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.89M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.
- Wells Fargo held 33,237 shares of RxSight worth $205K as of Q1 2026.
- Wells Fargo sold 75,294 RxSight shares in Q1 2026, an estimated $625K.
- RxSight made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4692 holding.
- Wells Fargo first reported a position in RxSight in Q3 2021 and has held it in 19 quarters since.
- Wells Fargo's RxSight position peaked at $2.89M in Q2 2024.
- 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.